
First Light Joins Global Initiative to Combat Antibiotic Resistance
Commits to deliver platform to enable targeted treatment at the onset of infection First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation in the U.S. Centers for Disease Control and Prevention (CDC) Antimicrobial Resistance (AMR) Challenge. First Light’s MultiPath™ platform will…

David Macdonald to Present at BIO Investor Forum
Two-day event highlights investment trends and opportunities in Life Sciences Chelmsford, MA (October 16, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced that First Light’s President & CEO, David Macdonald will be among the presenters at the 2019 BIO Investor…

Dr. Angela Caliendo Joins First Light Diagnostics Clinical Advisory Board
Chelmsford, MA (October 9, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Angela M. Caliendo, M.D., Ph.D., to the company’s world-class, international Clinical Advisory Board. “Angie’s expertise and deep research experience in the development of diagnostic tests…

Dr. Joanne Spadoro Joins First Light Diagnostics
New Senior VP of R&D and Regulatory Affairs will help guide product development and regulatory clearance. Chelmsford, MA, September 25, 2019 – First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced the addition of Dr. Joanne Spadoro as its Vice…

First Light Diagnostics MultiPath™ Part of Innovation Alley at IDWeek 2019
Chelmsford, MA, September 5, 2019 – First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced their participation at IDWeek 2019 from October 2 – 6 in Washington, DC. First Light Diagnostics will be exhibiting at booth 445. Representatives will be available…

First Light Diagnostics MultiPath™ Platform to be Showcased at AACC 2019
CHELMSFORD, Mass., July 31, 2019 (Newswire.com) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation at the American Association for Clinical Chemistry’s (AACC) 71st Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California from August 4-8. First Light Diagnostics will…

First Light Diagnostics Receives Technology Innovation Leader Award at Frost & Sullivan Gala
Chelmsford, MA – (July 24th, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, formally received their award for Technology Innovation at the 2019 Frost & Sullivan Excellence in Best Practices Awards Gala on July 17th at the San Diego Marriott La Jolla,…

First Light Adds New Multimedia to Website
New videos include 1-1 clinician interviews and detailed product tour Chelmsford, MA – (July 10th, 2019) First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the introduction of new multimedia content on the homepage of the First Light Diagnostics website. The new content…

First Light Diagnostics Announces Closing of a $4.5 million Debt Financing
Additional funds to support the company’s diagnostic platform initiatives Chelmsford, MA – (June 19, 2019) – First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced the closing of a $4.5 million debt financing. This includes a Lease Line with CSC…

First Light Diagnostics to Showcase MultiPath™ Platform at ASM Microbe 2019
CHELMSFORD, Mass., June 6, 2019 (Newswire.com) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced its participation at the American Society for Microbiology’s ASM Microbe 2019 Event in San Francisco, California, from June 20-24. First Light Diagnostics will be exhibiting in the Innovation Zone, the newest addition…